GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Viva Biotech Holdings (FRA:VB0) » Definitions » 3-Year Dividend Growth Rate

Viva Biotech Holdings (FRA:VB0) 3-Year Dividend Growth Rate : 0.00% (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Viva Biotech Holdings 3-Year Dividend Growth Rate?

Viva Biotech Holdings's Dividends per Share for the six months ended in Dec. 2024 was €0.00.

The historical rank and industry rank for Viva Biotech Holdings's 3-Year Dividend Growth Rate or its related term are showing as below:

FRA:VB0's 3-Year Dividend Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 8.95
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Viva Biotech Holdings's Dividend Payout Ratio for the six months ended in Dec. 2024 was 0.00. As of today, Viva Biotech Holdings's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Viva Biotech Holdings's 3-Year Dividend Growth Rate

For the Biotechnology subindustry, Viva Biotech Holdings's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Viva Biotech Holdings's 3-Year Dividend Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Viva Biotech Holdings's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Viva Biotech Holdings's 3-Year Dividend Growth Rate falls into.


;
;

Viva Biotech Holdings 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Viva Biotech Holdings  (FRA:VB0) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Viva Biotech Holdings's Dividend Payout Ratio for the quarter that ended in Dec. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2024 )/ EPS without NRI (Q: Dec. 2024 )
=0/ 0.002
=0.00

During the past 9 years, the highest Dividend Payout Ratio of Viva Biotech Holdings was 0.18. The lowest was 0.02. And the median was 0.05.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

During the past 9 years, the highest Dividend Yield of Viva Biotech Holdings was 0.82%. The lowest was 0.05%. And the median was 0.38%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Viva Biotech Holdings 3-Year Dividend Growth Rate Related Terms>


Viva Biotech Holdings Business Description

Traded in Other Exchanges
Address
735 Ziping Road, Pudong New District, Zhoupu Town, Shanghai, CHN, 201318
Viva Biotech Holdings is an integrated drug discovery platform. The company's operating segment includes Drug discovery services and Contract Development Manufacture Organisation (CDMO) and commercialisation services. It generates maximum revenue from the Contract Development Manufacture Organisation (CDMO) and commercialisation services segment. The Contract Development Manufacture Organisation (CDMO) and commercialisation services segment include contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates, and formulations. Geographically, the company generates a majority of its revenue from the United States of America, and the rest from the European Union, Chinese Mainland, Africa, and other regions.

Viva Biotech Holdings Headlines

No Headlines